Paolo Colombo

Emeritus Professor, Università degli Studi di Parma

“Collaboration on the basis of transparency, friendship and mutual consideration is key for anyone interested in fostering positive foreign partnerships. It is becoming increasingly evident that more needs to be done to combat orphan diseases. The deep involvement of international partners repurposing old drugs for new medicines using shared pharmaceutical technologies is of crucial importance.”

Part of the Power List 2019

Breakthroughs at the bench, novel technologies and groundbreaking policies and regulation have helped the pharma industry grow from strength to strength. After months of collating reader nominations and judging overseen by a panel of industry experts, we proudly present The Medicine Maker 2019 Power List, featuring 100 of the industry’s pioneers across four categories: Industry Influencers, Business Captains, Masters of the Bench, and Champions of Change.

Go to The Power List 2019